Changes in calcanean bone mineral occurring spontaneously and during hormone replacement therapy in early post-menopausal women

Scand J Clin Lab Invest. 1992 Dec;52(8):831-6. doi: 10.3109/00365519209088388.

Abstract

The spontaneous calcanean bone loss occurring in healthy early post-menopausal women and the effect of two hormone replacement therapies (HRT's) were investigated in a longitudinal study. There was no difference between the right and left calcanean BMC or BMD (p > 0.15). The spontaneous bone loss was similar at all the skeletal sites measured, with a mean spontaneous loss in calcanean BMD of 1.6% over one year. Both HRT's significantly (p < 0.01) prevented the bone loss from all skeletal sites irrespective of the weight-bearing or content of trabecular bone, and (for the weight-bearing bones) there was even a gain in calcanean BMC and BMD and spinal BMD (p < 0.01). Bone mineral of the calcaneus and the spine correlated equally to body weight (r approximately 0.4, p < 0.001), whereas bone mineral in the forearm was not correlated to body weight. The correlations between the changes in bone mineral at the sites measured were all significant (r approximately 0.2-0.4).

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Density / drug effects*
  • Calcaneus / drug effects*
  • Calcaneus / metabolism
  • Drug Therapy, Combination
  • Estradiol / analogs & derivatives
  • Estradiol / therapeutic use
  • Estrogen Replacement Therapy / methods*
  • Estrogens, Conjugated (USP) / therapeutic use
  • Female
  • Forearm
  • Humans
  • Levonorgestrel / administration & dosage
  • Longitudinal Studies
  • Lumbar Vertebrae / metabolism
  • Menopause / metabolism*
  • Middle Aged

Substances

  • Estrogens, Conjugated (USP)
  • Estradiol
  • Levonorgestrel